Submission to first decision
32 days

Clinical Pharmacokinetics promotes the continuing development of clinical pharmacokinetics and pharmacodynamics, for the improvement of drug therapy and to further postgraduate education in clinical pharmacology and therapeutics, by publishing critical and comprehensive review articles and clinically focussed original research articles. The Journal includes:
leading articles/current opinions providing an overview of emerging areas and contentious issues;
clinical pharmacokinetics and relevant pharmacodynamics of both single drugs and drug classes;
pharmacokinetic principles behind effective drug treatment of particular diseases;
new concepts and principles in pharmacokinetics;
application of therapeutic drug monitoring to optimize therapy;
prediction and avoidance of drug interactions;
new methodology in drug development and advances in drug delivery systems;
optimization of treatment for particular patient populations;
regulatory aspects of pharmacokinetics and pharmacodynamics, with their practical implications.
Additional enhanced features (including slide sets, videos and animations) can be published with articles; these are designed to increase the visibility,readership and educational value of the journal’s content. In addition, articles published in Clinical Pharmacokinetics may be accompanied by plain language summaries to assist readers in understanding important medical advances.
All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.

Editors (Adis International Limited, Auckland, New Zealand):
Amitabh Prakash
Anton van Rensburg
Editorial Board:
F. Akhlaghi, University of Rhode Island, Kingston, USA
K.M. Allegaert, University of Leuven, Leuven, Belgium
J.H. Beijnen, Utrecht University, Amsterdam, the Netherlands
H.R. Brunner, University of Lausanne, Lausanne, Switzerland
E. Chatelut, Institut Universitaire du Cancer Toulouse, Toulouse, France
S.J. Clarke, Royal North Shore Hospital, Sydney, NSW, Australia
J.L. Clements, Presbyterian College School of Pharmacy, Clinton, SC, USA
M.L. Dahl, Karolinska Institutet, Uppsala, Sweden
N.M. Davies, University of Alberta, Edmonton, AB, Canada
H. Derendorf, University of Florida, Gainesville, FL, USA
C.L. DeVane, Medical University of South Carolina, Charleston, SC, USA
S.N. de Wildt, Radboud University, Nijmegen, the Netherlands
T.C. Dowling, Ferris State University, Grand Rapids, MI, USA
S. Duffull, University of Otago, Dunedin, New Zealand
C.B. Eap, Hopital de Cery, Lausanne, Switzerland
H. Echizen, Meiji Pharmaceutical University, Tokyo, Japan
A.N. Edginton, University of Waterloo, Waterloo, ON, Canada
E. Eliasson, Karolinska University Hospital, Stockholm, Sweden
A. Ferro, King's College London, London, UK
B. Green, University of Queensland, Brisbane, QLD, Australia
S. Harirforoosh, East Tennessee State University, Johnson City, TN, USA
G. Hempel, Wilhelms-Universität Munster, Muster, Germany
R.W. Jelliffe, University of Southern California, Los Angeles, CA, USA
C. Kloft, Freie Universitaet Berlin, Berlin, Germany
C.A.J. Knibbe, Leiden University, Leiden; and St. Antonius Hospital, Nieuwegein, the Netherlands
J. Lötsch, Johann Wolfgang Goethe-University, Frankfurt, Germany
B. Meibohm, University of Tennessee, Memphis, TN, USA
F. Mentré, Universite Paris Diderot, Paris, France
G. Mikus, University of Heidelberg, Heidelberg, Germany
G.D. Morse, University of Buffalo, Buffalo, NY, USA
P.J. Neuvonen, University of Helsinki, Helsinki, Finland
F. Pea, University of Udine, Udine, Italy
E. Perucca, University of Pavia, Pavia, Italy
J.H. Proost, University of Groningen, Groningen, the Netherlands
M.S. Roberts, University of Queensland, Brisbane, QLD, Australia
A. Sánchez Navarro, Universidad de Salamanca, Salamanca, Spain
C.M.T. Sherwin, University of Utah, Salt Lake City, UT, USA
S. Tett, University of Queensland, Brisbane, QLD, Australia
M. Tod, Université Lyon, Paris, France
D.J. Touw, University Medical Center Groningen, Groningen, the Netherlands
V.V. Upreti, Amgen, CA, USA
J.N. vanden Anker, Children’s National Health System, Washington, DC, USA, and University Children’s Hospital, Basel, Switzerland
T. van Gelder, Erasmus Medical Center, Rotterdam, the Netherlands